Search - tctmd.com

Displaying 1 - 20 of 518

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2016

我对 2016 年 TCT 的总结：惊喜、假设和赠品

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Shelley Wood

November 07, 2016

Presentation TCT 2016

Editorial Comment: Current Techniques, Device Selection, and Outcomes

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Mahmood K. Razavi

November 01, 2016

Presentation TCT 2016

Editorial Comment: Current Guidelines, Device, and Anticoagulation Strategies

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Thomas D. Stuckey

November 01, 2016

Presentation TCT 2016

Featured Lecture: Balancing the Needs for Data Transparency and the Clinical Trial Enterprise

Presenter: Robert O. Bonow, Mitchell W. Krucoff, Manesh R. Patel

November 01, 2016

Presentation TCT 2016

Featured Lecture: A Personal Mission to Impact Cardiovascular Health: It Must Start With Children!

Presenter: Robert O. Bonow, Mitchell W. Krucoff, Valentin Fuster

November 01, 2016

Presentation TCT 2016

Bayesian Statistics: Utility and Interpretation

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Marc Etienne Jolicoeur

November 01, 2016

Presentation TCT 2016

Propensity-Matched Analysis: Advantages and Pitfalls

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Tracy Y. Wang

November 01, 2016

Presentation TCT 2016

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Somjot S. Brar

November 01, 2016

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Subgroup Analyses: How Useful or Harmful Are They?

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Sanjay Kaul

November 01, 2016

Presentation TCT 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber

November 01, 2016

Presentation TCT 2016

TCTMD Global PCI Map Project

Presenter: Ivan C. Rokos

October 31, 2016

Presentation TCT 2016

Nightmare in the Cath Lab

Presenter: George D. Dangas, Khaled Hammad

October 31, 2016

Presentation TCT 2016

Featured Lecture: The Rationale and Impact of New European Device Regulations

Presenter: Michael J. Mack, Aaron V. Kaplan, Alan G. Fraser

October 31, 2016

News Conference News TCT 2016

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

Social Media and the Internet: How to Make It Work for You and Your Career

Presenter: Edward Schloss

October 31, 2016

Advertisement

我对 2016 年 TCT 的总结：惊喜、假设和赠品

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Editorial Comment: Current Techniques, Device Selection, and Outcomes

Editorial Comment: Current Guidelines, Device, and Anticoagulation Strategies

Featured Lecture: Balancing the Needs for Data Transparency and the Clinical Trial Enterprise

Featured Lecture: A Personal Mission to Impact Cardiovascular Health: It Must Start With Children!

Bayesian Statistics: Utility and Interpretation

Propensity-Matched Analysis: Advantages and Pitfalls

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Subgroup Analyses: How Useful or Harmful Are They?

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

TCTMD Global PCI Map Project

Nightmare in the Cath Lab

Featured Lecture: The Rationale and Impact of New European Device Regulations

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Social Media and the Internet: How to Make It Work for You and Your Career

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content